TY - JOUR AU - Campo, E. AU - Swerdlow, S. H. AU - Harris, N. L. AU - Pileri, S. AU - Stein, H. AU - Jaffe, E. S. PY - 2011 DA - 2011// TI - The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications JO - Blood VL - 117 UR - https://doi.org/10.1182/blood-2011-01-293050 DO - 10.1182/blood-2011-01-293050 ID - Campo2011 ER - TY - JOUR AU - Smedby, K. E. AU - Hjalgrim, H. PY - 2011 DA - 2011// TI - Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes JO - Semin Cancer Biol VL - 21 UR - https://doi.org/10.1016/j.semcancer.2011.09.010 DO - 10.1016/j.semcancer.2011.09.010 ID - Smedby2011 ER - TY - JOUR AU - Leux, C. AU - Maynadié, M. AU - Troussard, X. AU - Cabrera, Q. AU - Herry, A. AU - Guyader-Peyrou, S. PY - 2014 DA - 2014// TI - Mantle cell lymphoma epidemiology: a population-based study in France JO - Ann Hematol VL - 93 UR - https://doi.org/10.1007/s00277-014-2049-5 DO - 10.1007/s00277-014-2049-5 ID - Leux2014 ER - TY - JOUR AU - Shah, B. D. AU - Martin, P. AU - Sotomayor, E. M. PY - 2012 DA - 2012// TI - Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches JO - Cancer Control J Moffitt Cancer Cent VL - 19 ID - Shah2012 ER - TY - JOUR AU - Schöllkopf, C. AU - Melbye, M. AU - Munksgaard, L. AU - Smedby, K. E. AU - Rostgaard, K. AU - Glimelius, B. PY - 2008 DA - 2008// TI - Borrelia infection and risk of non-Hodgkin lymphoma JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-08-109611 DO - 10.1182/blood-2007-08-109611 ID - Schöllkopf2008 ER - TY - JOUR AU - Wang, S. S. AU - Slager, S. L. AU - Brennan, P. AU - Holly, E. A. AU - Sanjose, S. AU - Bernstein, L. PY - 2007 DA - 2007// TI - Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph) JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-06-031948 DO - 10.1182/blood-2006-06-031948 ID - Wang2007 ER - TY - JOUR AU - Skibola, C. F. AU - Bracci, P. M. AU - Nieters, A. AU - Brooks-Wilson, A. AU - Sanjosé, S. AU - Hughes, A. M. PY - 2010 DA - 2010// TI - Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium JO - Am J Epidemiol VL - 171 UR - https://doi.org/10.1093/aje/kwp383 DO - 10.1093/aje/kwp383 ID - Skibola2010 ER - TY - STD TI - Dreyling M, Hiddemann W, European MCL Network. Current treatment standards and emerging strategies in mantle cell lymphoma. Hematol Educ Program Am Soc Hematol. 2009;542–51. ID - ref8 ER - TY - JOUR AU - Vose, J. M. PY - 2012 DA - 2012// TI - Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management JO - Am J Hematol VL - 87 UR - https://doi.org/10.1002/ajh.23176 DO - 10.1002/ajh.23176 ID - Vose2012 ER - TY - JOUR AU - Chandran, R. AU - Gardiner, S. K. AU - Simon, M. AU - Spurgeon, S. E. PY - 2012 DA - 2012// TI - Survival trends in mantle cell lymphoma in the United States over 16 years 1992–2007 JO - Leuk Lymphoma VL - 53 UR - https://doi.org/10.3109/10428194.2012.656628 DO - 10.3109/10428194.2012.656628 ID - Chandran2012 ER - TY - JOUR AU - Hoster, E. AU - Dreyling, M. AU - Klapper, W. AU - Gisselbrecht, C. AU - Hoof, A. AU - Kluin-Nelemans, H. C. PY - 2008 DA - 2008// TI - A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-06-095331 DO - 10.1182/blood-2007-06-095331 ID - Hoster2008 ER - TY - JOUR AU - Gerlinger, M. AU - Rowan, A. J. AU - Horswell, S. AU - Larkin, J. AU - Endesfelder, D. AU - Gronroos, E. PY - 2012 DA - 2012// TI - Intratumor heterogeneity and branched evolution revealed by multiregion sequencing JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1113205 DO - 10.1056/NEJMoa1113205 ID - Gerlinger2012 ER - TY - JOUR AU - Onakpoya, I. J. AU - Spencer, E. A. AU - Thompson, M. J. AU - Heneghan, C. J. PY - 2015 DA - 2015// TI - Effectiveness, safety and costs of orphan drugs: an evidence-based review JO - BMJ Open VL - 5 UR - https://doi.org/10.1136/bmjopen-2014-007199 DO - 10.1136/bmjopen-2014-007199 ID - Onakpoya2015 ER - TY - JOUR AU - Wang, M. L. AU - Rule, S. AU - Martin, P. AU - Goy, A. AU - Auer, R. AU - Kahl, B. S. PY - 2013 DA - 2013// TI - Targeting BTK with Ibrutinib in relapsed or refractory mantle-cell lymphoma JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1306220 DO - 10.1056/NEJMoa1306220 ID - Wang2013 ER - TY - JOUR AU - Campo, E. AU - Rule, S. PY - 2015 DA - 2015// TI - Mantle cell lymphoma: evolving management strategies JO - Blood VL - 125 UR - https://doi.org/10.1182/blood-2014-05-521898 DO - 10.1182/blood-2014-05-521898 ID - Campo2015 ER - TY - JOUR AU - Souers, A. J. AU - Leverson, J. D. AU - Boghaert, E. R. AU - Ackler, S. L. AU - Catron, N. D. AU - Chen, J. PY - 2013 DA - 2013// TI - ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets JO - Nat Med VL - 19 UR - https://doi.org/10.1038/nm.3048 DO - 10.1038/nm.3048 ID - Souers2013 ER - TY - JOUR AU - Touzeau, C. AU - Dousset, C. AU - Gouill, S. AU - Sampath, D. AU - Leverson, J. D. AU - Souers, A. J. PY - 2014 DA - 2014// TI - The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma JO - Leukemia VL - 28 UR - https://doi.org/10.1038/leu.2013.216 DO - 10.1038/leu.2013.216 ID - Touzeau2014 ER - TY - JOUR AU - Chiron, D. AU - Dousset, C. AU - Brosseau, C. AU - Touzeau, C. AU - Maïga, S. AU - Moreau, P. PY - 2015 DA - 2015// TI - Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3275 DO - 10.18632/oncotarget.3275 ID - Chiron2015 ER - TY - JOUR AU - Allart-Vorelli, P. AU - Porro, B. AU - Baguet, F. AU - Michel, A. AU - Cousson-Gélie, F. PY - 2015 DA - 2015// TI - Haematological cancer and quality of life: a systematic literature review JO - Blood Cancer J VL - 5 UR - https://doi.org/10.1038/bcj.2015.29 DO - 10.1038/bcj.2015.29 ID - Allart-Vorelli2015 ER - TY - JOUR AU - Jensen, R. E. AU - Arora, N. K. AU - Bellizzi, K. M. AU - Rowland, J. H. AU - Hamilton, A. S. AU - Aziz, N. M. PY - 2013 DA - 2013// TI - Health-related quality of life among survivors of aggressive non-Hodgkin lymphoma: HRQOL among survivors of aggressive NHL JO - Cancer VL - 119 UR - https://doi.org/10.1002/cncr.27781 DO - 10.1002/cncr.27781 ID - Jensen2013 ER - TY - JOUR AU - Smith, S. K. AU - Mayer, D. K. AU - Zimmerman, S. AU - Williams, C. S. AU - Benecha, H. AU - Ganz, P. A. PY - 2013 DA - 2013// TI - Quality of life among long-term survivors of non-Hodgkin Lymphoma: a follow-up study JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2011.40.6249 DO - 10.1200/JCO.2011.40.6249 ID - Smith2013 ER - TY - JOUR AU - Oken, M. M. AU - Creech, R. H. AU - Tormey, D. C. AU - Horton, J. AU - Davis, T. E. AU - McFadden, E. T. PY - 1982 DA - 1982// TI - Toxicity and response criteria of the Eastern Cooperative Oncology Group JO - Am J Clin Oncol VL - 5 UR - https://doi.org/10.1097/00000421-198212000-00014 DO - 10.1097/00000421-198212000-00014 ID - Oken1982 ER - TY - STD TI - A predictive model for aggressive non-Hodgkin’s lymphoma. The International non-Hodgkin’s lymphoma prognostic factors project. N Engl J Med. 1993;329:987–94. ID - ref23 ER - TY - JOUR AU - Trotti, A. AU - Colevas, A. AU - Setser, A. AU - Rusch, V. AU - Jaques, D. AU - Budach, V. PY - 2003 DA - 2003// TI - CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment JO - Semin Radiat Oncol VL - 13 UR - https://doi.org/10.1016/S1053-4296(03)00031-6 DO - 10.1016/S1053-4296(03)00031-6 ID - Trotti2003 ER - TY - JOUR AU - Linn, B. S. AU - Linn, M. W. AU - Gurel, L. PY - 1968 DA - 1968// TI - Cumulative illness rating scale JO - J Am Geriatr Soc VL - 16 UR - https://doi.org/10.1111/j.1532-5415.1968.tb02103.x DO - 10.1111/j.1532-5415.1968.tb02103.x ID - Linn1968 ER - TY - JOUR AU - Ware, J. E. AU - Sherbourne, C. D. PY - 1992 DA - 1992// TI - The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection JO - Med Care VL - 30 UR - https://doi.org/10.1097/00005650-199206000-00002 DO - 10.1097/00005650-199206000-00002 ID - Ware1992 ER - TY - BOOK AU - Brooks, R. AU - Rabin, R. AU - Charro, F. PY - 2003 DA - 2003// TI - The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective Evidence from the EuroQol BIOMED Research Programme [Internet] PB - Springer Netherlands CY - Dordrecht UR - https://doi.org/10.1007/978-94-017-0233-1 DO - 10.1007/978-94-017-0233-1 ID - Brooks2003 ER - TY - JOUR AU - Hlubocky, F. J. AU - Webster, K. AU - Cashy, J. AU - Beaumont, J. AU - Cella, D. PY - 2013 DA - 2013// TI - The development and validation of a measure of health-related quality of life for non-Hodgkin’s lymphoma: the functional assessment of cancer therapy—lymphoma (FACT-Lym) JO - Lymphoma VL - 2013 UR - https://doi.org/10.1155/2013/147176 DO - 10.1155/2013/147176 ID - Hlubocky2013 ER - TY - JOUR AU - Vegliante, M. C. AU - Palomero, J. AU - Perez-Galan, P. AU - Roue, G. AU - Castellano, G. AU - Navarro, A. PY - 2013 DA - 2013// TI - SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-06-438937 DO - 10.1182/blood-2012-06-438937 ID - Vegliante2013 ER - TY - JOUR AU - Surget, S. AU - Chiron, D. AU - Gomez-Bougie, P. AU - Descamps, G. AU - Ménoret, E. AU - Bataille, R. PY - 2012 DA - 2012// TI - Cell death via DR5, but not DR4, is regulated by p53 in myeloma cells JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-12-0487 DO - 10.1158/0008-5472.CAN-12-0487 ID - Surget2012 ER - TY - JOUR AU - Touzeau, C. AU - Ryan, J. AU - Guerriero, J. AU - Moreau, P. AU - Chonghaile, T. N. AU - Gouill, S. PY - 2016 DA - 2016// TI - BH3 profiling identifies heterogeneous dependency on Bcl-2 family members in multiple myeloma and predicts sensitivity to BH3 mimetics JO - Leukemia VL - 30 UR - https://doi.org/10.1038/leu.2015.184 DO - 10.1038/leu.2015.184 ID - Touzeau2016 ER - TY - JOUR AU - Burger, J. A. AU - Ford, R. J. PY - 2011 DA - 2011// TI - The microenvironment in mantle cell lymphoma: Cellular and molecular pathways and emerging targeted therapies JO - Semin Cancer Biol VL - 21 UR - https://doi.org/10.1016/j.semcancer.2011.09.006 DO - 10.1016/j.semcancer.2011.09.006 ID - Burger2011 ER - TY - JOUR AU - Klanova, M. AU - Soukup, T. AU - Jaksa, R. AU - Molinsky, J. AU - Lateckova, L. AU - Maswabi, B. C. L. PY - 2014 DA - 2014// TI - Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research JO - Lab Investig J Tech Methods Pathol VL - 94 UR - https://doi.org/10.1038/labinvest.2014.61 DO - 10.1038/labinvest.2014.61 ID - Klanova2014 ER - TY - BOOK PY - 2013 DA - 2013// TI - R: A language and environment for statistical computing [Internet] PB - R Foundation for Statistical Computing CY - Vienna ID - ref34 ER -